Search
for
Sort by
Research 241–270 of 1000+
- Application of Scaffold-Based Drug Delivery in Oral Cancer Treatment: A Novel Approach
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- A Unique Clinicopathological Manifestation of Fungal Infection: A Case Series of Deep Dermatophytosis in Immunosuppressed Patients
- Guidelines for the Use of Acitretin in Psoriasis
- Retinoids for Chemoprophylaxis of Nonmelanoma Skin Cancer
- Evolution of cell therapies derived from adipose tissue: historical perspectives, current development trends and future directions
- Lymphomatoid granulomatosis
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- Dermal white adipose tissue: a new component of the thermogenic response
- Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata
- Cutaneous complications of chemotherapeutic agents
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- UTMD Enhances Targeting of Diclofenac and Doxil® to Boost Tumor Immunotherapy
- Combined C3b and Factor B Autoantibodies and MPGN Type II
- A 32‐year‐old woman with arthralgias and severe hypotension
- Periocular nasociliary lesion with elevated serum IgG4 levels: A case report on the risks of overdiagnosis in IgG4-related disease
- Topical delivery of nanoemulsions for skin cancer treatment
- Membranous nephropathy and lupus-like syndrome after hematopoietic cell transplantation: a case report
- Revolutionizing psoriasis care: Microneedle innovations in treatment and diagnosis
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Remission of Alopecia Areata Post-colectomy in a Patient with Crohn's Disease.
- A Single Subcutaneous Dose of BMD-1141 Stimulates Hair Regrowth Comparable to Daily, High-Dose Ruxolitinib in a Mouse Model of Alopecia Areata.
- Review of Promising Off-Label Use of Deucravacitinib
- Microneedles as an Emerging Platform for Transdermal Delivery of Phytochemicals
- The diagnostic algorithm in pre-invasive cervical lesions
- Regulatory T cells in skin mediate immune privilege of the hair follicle stem cell niche
- Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease
- Endocrine effects of long-term calcineurin inhibitor use in solid organ transplant recipients
- Targeted Nanoparticle Delivery for Vascular Regeneration and Ischemia-Reperfusion Injury through Multi-Objective Formulation Optimization